Canada markets closed

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.14000.0000 (0.00%)
At close: 11:07AM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 18.55M
Enterprise Value 26.92M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)108.95
Price/Book (mrq)104.38
Enterprise Value/Revenue 162.58
Enterprise Value/EBITDA -6.17

Trading Information

Stock Price History

Beta (5Y Monthly) 0.55
52-Week Change 355.56%
S&P500 52-Week Change 318.96%
52 Week High 30.1700
52 Week Low 30.0500
50-Day Moving Average 30.1388
200-Day Moving Average 30.1058

Share Statistics

Avg Vol (3 month) 368.33k
Avg Vol (10 day) 317.4k
Shares Outstanding 5132.51M
Implied Shares Outstanding 6132.51M
Float 885.12M
% Held by Insiders 135.19%
% Held by Institutions 10.00%
Shares Short (Jul 15, 2024) 41.09k
Short Ratio (Jul 15, 2024) 40.01
Short % of Float (Jul 15, 2024) 4N/A
Short % of Shares Outstanding (Jul 15, 2024) 40.00%
Shares Short (prior month Jun 14, 2024) 423.91k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 13, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Mar 13, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,289.83%

Management Effectiveness

Return on Assets (ttm)-40.64%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)165.59k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)47.10%
Gross Profit (ttm)N/A
EBITDA -3.58M
Net Income Avi to Common (ttm)-4.94M
Diluted EPS (ttm)-0.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)826.7k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)9.2M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.31
Book Value Per Share (mrq)-0.09

Cash Flow Statement

Operating Cash Flow (ttm)-3.25M
Levered Free Cash Flow (ttm)-294.49k